Bliss GVS Pharma’s marketing and distribution partner -- Rising Pharma Holdings, Inc. USA has received final approval from the U.S. Food & Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) for the product ‘Mesalamine Suppositories 1000 mg’. The ANDA was submitted through the company’s partner in the USA.
Bliss GVS Pharma is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market.
